title: Response to the letter "No evidence to support high-intensity statin in Chinese patients with coronary heart disease".
authors.affiliation: Research Center for Translational Medicine, Shanghai East Hospital Affiliated to Tongji University School of Medicine, Shanghai 200120, China; Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.
authors.forename: Brian
authors.initials: B
authors.lastname: Tomlinson
authors.affiliation: Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.
authors.forename: Miao
authors.initials: M
authors.lastname: Hu
authors.affiliation: Research Center for Translational Medicine, Shanghai East Hospital Affiliated to Tongji University School of Medicine, Shanghai 200120, China.
authors.forename: Yuzhen
authors.initials: Y
authors.lastname: Zhang
authors.affiliation: Department of Cardiac Surgery, Shanghai East Hospital, Tongji University, Shanghai, China.
authors.forename: Zhong-Min
authors.initials: ZM
authors.lastname: Liu
authors.affiliation: Division of Cardiology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan. Electronic address: chanpaul@wanfang.gov.tw.
authors.forename: Paul
authors.initials: P
authors.lastname: Chan
mesh_terms: D003324:Coronary Artery Disease / Q000188:drug therapy*; D003327:Coronary Disease / Q000188:drug therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: Chinese; Statins